Showing results (2871-2880 of 13,857) with videos related to

Sort By:
Pageof 1,386
American Heart Journal|September 15, 2019
Comparison of the Cardiovascular Benefits of Resistance, Aerobic, and Combined Exercise (CardioRACE): Rationale, design, and methodsAngelique G Brellenthin, Lorraine M Lanningham-Foster, Marian L Kohut, et al.
American Heart Journal|September 15, 2019
Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trialKausik K Ray, Stephen J Nicholls, Henry D Ginsberg, et al.
American Heart Journal|September 15, 2019
Small-for-gestational-age birth is linked to cardiovascular dysfunction in early childhoodMatteo Castagno, Veronica Menegon, Alice Monzani, et al.
American Heart Journal|January 27, 2021
Periodontal Disease, Atrial Fibrillation and StrokeSouvik Sen, Kolby Redd, Tushar Trivedi, et al.
American Heart Journal|January 28, 2021
Prevalence of ideal cardiovascular health in young adults: A birth cohort from southern BrazilRicardo Santos Oliveira, Bruna Celestino Schneider, Gabriela Callo-Quinte, et al.
American Heart Journal|September 8, 2019
A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) studyR Mark Payne, Kristin M Burns, Andrew C Glatz, et al.
American Heart Journal|February 12, 2021
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD studyWarren H Capell, Elliot S Barnathan, Gregory Piazza, et al.
American Heart Journal|February 23, 2021
Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trialZhen Ge, Xiao-Fei Gao, Jing Kan, et al.
American Heart Journal|February 24, 2021
Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population studyW H Wilson Tang, Xinmin S Li, Yuping Wu, et al.
American Heart Journal|April 1, 1988
Left ventricular dysfunction in excess of the size of infarction: a possible management strategyM L Smucker, G A Beller, D D Watson, et al.
Pageof 1,386